Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials
Sign Up to like & getrecommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26711
Abstract: Lesion length has been an important factor in predicting a worse outcome after percutaneous coronary interventions (PCI); however, the safety and efficacy of second‐generation drug eluting stents in very long coronary lesions has not been… read more here.
Keywords: treatment long; clinical outcomes; xience; pci treatment ... See more keywords
Design and Rationale of the XIENCE Short DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-month DAPT in Patients at High Bleeding Risk Undergoing PCI with an Everolimus-Eluting Stent.
Sign Up to like & getrecommendations! Published in 2020 at "American heart journal"
DOI: 10.1016/j.ahj.2020.09.019
Abstract: Dual antiplatelet therapy (DAPT) is key for the prevention of recurrent ischemic events after percutaneous coronary intervention (PCI), however, it increases the risk of bleeding complications. While new generation drug-eluting stents have been shown superior… read more here.
Keywords: dapt; program; xience short; xience ... See more keywords
TCT-539 Clinical outcomes in high bleeding risk patients undergoing complex PCI with the Xience everolimus eluting stent: a patient-level pooled analysis from four Xience post-approval trials
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.1723
Abstract: High bleeding risk (HBR) patients experience not only high risk for bleeding but also high risk for ischemic events. Similarly, complex vs. non-complex PCI is generally associated with increased ischemic risk. We aimed to evaluate… read more here.
Keywords: risk; high bleeding; xience; complex pci ... See more keywords
Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parallel-Designed, Single Blind Test.
Sign Up to like & getrecommendations! Published in 2022 at "Korean circulation journal"
DOI: 10.4070/kcj.2021.0198
Abstract: BACKGROUND AND OBJECTIVES To compare the safety and efficacy of a new everolimus-eluting stent with an abluminal-coated biodegradable polymer (Osstem Cardiotec Centum) with those of the Xience Alpine stent (Xience). METHODS This randomized, prospective, multicenter,… read more here.
Keywords: stent; xience; cardiotec centum; osstem cardiotec ... See more keywords